CLBT · CIK 0001854587
Cellebrite DI Ltd.
What Cellebrite DI Ltd. owns has not been researched yet. This page is its ownership register, who holds it, and the absence of holdings below means nobody has looked rather than that there is nothing to find.
Cellebrite DI Ltd. - Profile
- Industry
- Services-Prepackaged SoftwareSIC 7372
- Listed on
- Nasdaq
- Employees
- 1,285stated 2025
- Financial year ends
- 31 December
Source
Address, industry classification, listing and incorporation come from Cellebrite DI Ltd.'s own SEC filer record, so the industry is the SEC's dry classification rather than a marketing label. The headcount is the figure the sources below state for 2025. The description was written for this site in August 2026 from Cellebrite DI Ltd. Form 20-F for fiscal year 2025 and SEC EDGAR filing index for Cellebrite DI Ltd. Form 20-F, filed 3 March 2026, not taken from any single article.
Share price
CLBT
Description
Cellebrite DI Ltd., headquartered in Petah Tikva, Israel and listed on Nasdaq, sells digital forensics and investigative software used to access, collect, review, analyze, share and manage digital evidence. Its Inseyets suite extracts and decodes data from mobile phones, computers and cloud applications in legally sanctioned investigations, its Guardian and Pathfinder products cover evidence management and AI-assisted analytics, and the December 2025 acquisition of Corellium added Arm device virtualization for mobile research and application security testing. Revenue for 2025 was $475.7 million: subscription services $330.8 million, term licenses $96.2 million, professional services $30.9 million and other non-recurring $17.8 million. Operating income was $66.5 million, and annual recurring revenue was $481 million at year end. By region the Americas produced $256.6 million, EMEA $161.4 million and APAC $57.7 million. The company reports approximately 7,000 customers, about 5,300 of them federal, state and local agencies and about 1,700 corporations and service providers, with public sector customers accounting for more than 90% of 2025 revenue. It had 1,285 full-time employees at 31 December 2025.
Who owns Cellebrite DI Ltd..
Nothing recorded on this side. That is a sourced finding rather than a gap where the research notes say so: see the notes below.
Select a row or a slice for its provenance: the filing it came from, when it was measured, and the arithmetic behind it if it was modelled.
The full register, from 13F filings
The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 218 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.
218 managers reported a position, together holding 126.6m shares. The 40 largest are listed.
Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.
What a reader needs to know to read these numbers
- Added 22 Aug 2026 by scripts/promote_discovered.py. This company reached the site because a covered investor holds it, not because an index listed it: it was a position in a portfolio here with no page of its own. The match was proved by requiring the register built for this CIK to contain the same CUSIP the portfolio held.
- Discovered at CUSIP M2197Q107, held by axon, bank-of-america, blackrock, bny-mellon, capital-group, citigroup, fidelity-fmr, fifth-third, franklin-resources, geode, goldman-sachs, huntington-bancshares, jpmorgan, morgan-stanley, northern-trust, pnc, raymond-james, regions-financial, state-street, us-bancorp, vanguard, wells-fargo.
- Holdings are NOT researched. The empty holdings list means nobody has looked at what this company owns, not that it owns nothing, and the page says so.
- Shares outstanding and market cap are null rather than guessed. Neither was captured on the dated sweep that carries every other company here.
Looked for, not found
Recorded rather than filled in. Each of these is a place where a number could have been invented and was not.
- Shares outstanding.
- Market capitalisation.